Illumina Innovation Fund II GP, L.L.C.

USReporting entity

Insider

Illumina Innovation Fund II GP, L.L.C.

USReporting entity

Transactions

Issuers

Buys / Sells

1/0

Last tx

20 Apr 2026

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Alamar Biosciences, Inc.	0	reported	20 Apr 2026	tx 13+11,874,128−18,699,449

Recent transactions

Date	Type	Issuer	Qty	Price
20 Apr 2026	CONVERSION	Alamar Biosciences, Inc.	4,588,364	—
20 Apr 2026	CONVERSION	Alamar Biosciences, Inc.	922,152	—
20 Apr 2026	OTHER	Alamar Biosciences, Inc.	5,510,516	—
20 Apr 2026	OTHER	Alamar Biosciences, Inc.	5,510,516	—
20 Apr 2026	CONVERSION	Alamar Biosciences, Inc.	346,020	—

InsiderLens aggregates public information issued by financial regulators (SEC, AMF, FCA, BaFin, AFM, FI, HKEX, ASX). The service constitutes neither investment advice nor a recommendation to buy or sell. Past performance is no guarantee of future results. Investing in financial instruments carries the risk of capital loss.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Alamar Biosciences, Inc.	0	reported	20 Apr 2026	tx 13+11,874,128−18,699,449

Recent transactions

Date	Type	Issuer	Qty	Price
20 Apr 2026	CONVERSION	Alamar Biosciences, Inc.	4,588,364	—
20 Apr 2026	CONVERSION	Alamar Biosciences, Inc.	922,152	—
20 Apr 2026	OTHER	Alamar Biosciences, Inc.	5,510,516	—
20 Apr 2026	OTHER	Alamar Biosciences, Inc.	5,510,516	—
20 Apr 2026	CONVERSION	Alamar Biosciences, Inc.	346,020	—